D2 dopamine receptors are a subtype of dopamine receptors that play a crucial role in the central nervous system (CNS) and the peripheral nervous system. Here's a concise and medically grounded overview:

🧠 D2 Dopamine Receptors: Key Facts

🔹 Classification

• Part of the D2-like receptor family, which includes D2, D3, and D4 receptors.
• G protein–coupled receptor (GPCR) that primarily inhibits adenylyl cyclase via Gi/o proteins.

🔹 Location

CNS:

• Striatum (motor control)
• Substantia nigra (movement regulation)
• Ventral tegmental area (VTA) (reward, motivation)
• Pituitary gland (prolactin regulation)

Peripheral:

• Enteric nervous system (modulates gastrointestinal motility)
• Chemoreceptor trigger zone (CTZ) – involved in nausea and vomiting

🔹 Functions

• Motor control (modulation of movement via the basal ganglia)
• Inhibition of prolactin secretion (via the pituitary gland)
• Modulation of reward and addiction circuits
• Regulation of nausea/vomiting (especially relevant in antiemetic pharmacology)

💊 Clinical Relevance

Antagonists of D2 receptors:

• Antipsychotics (e.g., haloperidol, risperidone) block D2 to reduce psychotic symptoms.
• Antiemetics/prokinetics (e.g., domperidone, metoclopramide) block peripheral D2 receptors to reduce nausea and enhance gastric motility.

Agonists:

Used in Parkinson’s disease (e.g., bromocriptine, pramipexole) to enhance dopaminergic signaling.

⚠️ Side Effects of D2 Blockade

• Extrapyramidal symptoms (EPS) – due to CNS D2 receptor blockade.
• Hyperprolactinemia – from reduced D2 inhibition in the pituitary.
• GI effects – both therapeutic (prokinetic) and adverse (e.g., diarrhea).